CE

CELLUMED CO., LTD.

Develops and manufactures medical devices, tissue grafts, and advanced biologics.

049180 | KO

Overview

Corporate Details

ISIN(s):
KR7049180003
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로 130 402(가산동, 에이스테크노타워 9차), 서울특별시

Description

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
기타주요경영사항 (제3자배정 유상증자 소액공모 철회의 건)
Korean 6.5 KB
2025-09-19 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 31.4 KB
2025-09-19 00:00
[기재정정]소액공모공시서류(지분증권)
Korean 1.9 MB
2025-09-19 00:00
소액공모실적보고서
Korean 26.0 KB
2025-08-26 00:00
주식등의대량보유상황보고서(일반)
Korean 109.8 KB
2025-08-25 00:00
투자판단관련주요경영사항 (채권압류 및 전부명령 항고 취하의 건)
Korean 8.2 KB
2025-08-25 00:00
주식등의대량보유상황보고서(약식)
Korean 72.5 KB
2025-08-18 00:00
투자판단관련주요경영사항 (집행판결 청구소송 합의의 건)
Korean 13.8 KB
2025-08-14 00:00
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.9 MB
2025-07-28 00:00
소송등의판결ㆍ결정(일정금액이상의청구) (특허권 압류명령)
Korean 12.3 KB
2025-07-25 00:00
투자판단관련주요경영사항 (채권압류 및 전부명령 판결에 대한 항고의 건)
Korean 10.0 KB
2025-07-11 00:00
투자판단관련주요경영사항 (주식압류명령의 판결에 대한 항고의 건)
Korean 9.3 KB
2025-06-13 00:00
소송등의판결ㆍ결정(일정금액이상의청구) (채권압류 및 전부명령)
Korean 12.5 KB
2025-06-13 00:00
소송등의판결ㆍ결정(일정금액이상의청구) (주식압류명령)
Korean 14.2 KB

Automate Your Workflow. Get a real-time feed of all CELLUMED CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CELLUMED CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CELLUMED CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.